Literature DB >> 18581603

A case of multiple endocrine neoplasia type 1 combined with papillary thyroid carcinoma.

Hai-Jin Kim1, Jong-Suk Park, Chul-Sik Kim, Eun-Seok Kang, Bong-Soo Cha, Sung-Kil Lim, Kyung-Rae Kim, Hyun-Chul Lee, Chul-Woo Ahn.   

Abstract

This is the first report of papillary thyroid carcinoma combined with multiple endocrine neoplasia type 1 (MEN1) in Korea. MEN1 is a hereditary disease comprising neoplastic disorders such as pituitary, parathyroid and pancreatic neuroendocrine tumor, such as gastrinoma. But papillary thyroid cancer was never regarded as its component before in Korea. Herein we present a 39-year-old woman who manifested typical features of MEN1 with a coincidental papillary thyroid carcinoma. Although the family history of MEN1 was definite, her genetic analysis of DNA had revealed no germline mutation in MEN1 gene locus. Unidentified culprit gene unable us further genetic study to find LOH (loss of heterogeneity) in 11q13, the possible explanation of papillary thyroid carcinoma as a new component of MEN1. As we have first experienced a case of MEN1 combined with papillary thyroid carcinoma in Korea, we report it with the review of literature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581603      PMCID: PMC2615331          DOI: 10.3349/ymj.2008.49.3.503

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  16 in total

1.  Genetic analysis of a papillary thyroid carcinoma in a patient with MEN1.

Authors:  D Desai; L A McPherson; J P Higgins; R J Weigel
Journal:  Ann Surg Oncol       Date:  2001-05       Impact factor: 5.344

2.  Radiation exposure and the simultaneous occurrence of primary hyperparathyroidism and thyroid nodules.

Authors:  R H Nishiyama; D Farhi; N W Thompson
Journal:  Surg Clin North Am       Date:  1979-02       Impact factor: 2.741

3.  Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.

Authors:  A O Vortmeyer; I A Lubensky; M Skarulis; G Li; Y W Moon; W S Park; R Weil; C Barlow; A M Spiegel; S J Marx; Z Zhuang
Journal:  Mod Pathol       Date:  1999-09       Impact factor: 7.842

4.  Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.

Authors:  E Friedman; K Sakaguchi; A E Bale; A Falchetti; E Streeten; M B Zimering; L S Weinstein; W O McBride; Y Nakamura; M L Brandi
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

5.  Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).

Authors:  Terry C Lairmore; Linda D Piersall; Mary K DeBenedetti; William G Dilley; Matthew G Mutch; Alison J Whelan; Barbara Zehnbauer
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

6.  Associated hyperparathyroidism and nonmedullary thyroid carcinoma: the etiologic role of radiation.

Authors:  I Hedman; L E Tisell
Journal:  Surgery       Date:  1984-04       Impact factor: 3.982

7.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

Authors:  C Larsson; B Skogseid; K Oberg; Y Nakamura; M Nordenskjöld
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

8.  Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders.

Authors:  J-H Park; I-J Kim; H C Kang; S-H Lee; Y Shin; K-H Kim; S-B Lim; S-B Kang; Ku Lee; S Y Kim; M-S Lee; M-K Lee; J-H Park; S-D Moon; J-G Park
Journal:  Clin Genet       Date:  2003-07       Impact factor: 4.438

9.  Concomitant Graves' disease and primary hyperparathyroidism. Influence of hyperthyroidism on serum calcium and parathyroid hormone.

Authors:  R Arem; M A Lim-Abrahan; L E Mallette
Journal:  Am J Med       Date:  1986-04       Impact factor: 4.965

10.  Simultaneous primary hyperparathyroidism and nodular thyroid disease.

Authors:  R A Prinz; A L Barbato; S S Braithwaite; M H Brooks; M A Emanuele; D L Gordon; A M Lawrence; E Paloyan
Journal:  Surgery       Date:  1982-09       Impact factor: 3.982

View more
  6 in total

1.  A rare case of primary hyperparathyroidism associated with primary aldosteronism, Hürthle cell thyroid cancer and meningioma.

Authors:  You Lim Kim; Young Woo Jang; Jin Taek Kim; Su Ah Sung; Tae Seok Lee; Won Mi Lee; Hyo Jeong Kim
Journal:  J Korean Med Sci       Date:  2012-04-25       Impact factor: 2.153

2.  Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion.

Authors:  Michael J Hall; Julie Innocent; Christina Rybak; Colleen Veloski; Walter J Scott; Hong Wu; John A Ridge; John P Hoffman; Hossein Borghaei; Aruna Turaka; Mary B Daly
Journal:  Appl Clin Genet       Date:  2015-02-17

3.  Lung adenocarcinoma and adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1.

Authors:  Nobumasa Ohara; Masanori Kaneko; Masahiro Ikeda; Fumio Ishizaki; Kazuya Suzuki; Ryo Maruyama; Takeshi Komeyama; Kazuhiro Sato; Kenichi Togashi; Hiroyuki Usuda; Yuto Yamazaki; Hironobu Sasano; Kenzo Kaneko; Kyuzi Kamoi
Journal:  Respir Med Case Rep       Date:  2016-12-18

Review 4.  Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations.

Authors:  Chiara Mele; Monica Mencarelli; Marina Caputo; Stefania Mai; Loredana Pagano; Gianluca Aimaretti; Massimo Scacchi; Alberto Falchetti; Paolo Marzullo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-18       Impact factor: 5.555

5.  Multiple endocrine neoplasia type 1 combined with thyroid neoplasm: A case report and review of literatures.

Authors:  Jia-Lu Xu; Su Dong; Le-Le Sun; Jin-Xin Zhu; Jia Liu
Journal:  World J Clin Cases       Date:  2022-01-21       Impact factor: 1.337

6.  Simultaneous EUS-FNA Diagnosis and TNM Staging of a Pancreatic Neuroendocrine Tumor in a Patient with an Unrecognized MEN Type 1.

Authors:  Francesco Ferrara; Carmelo Luigiano; Antonella Maimone; Marco Bassi; Anna Maria Polifemo; Paola Baccarini; Vincenzo Cennamo; Nadia Cremonini; Carlo Fabbri
Journal:  Case Rep Oncol Med       Date:  2012-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.